Roland Nnaemeka Okoro
Overview
Explore the profile of Roland Nnaemeka Okoro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Okoro R, Nduaguba S
Explor Res Clin Soc Pharm
. 2022 Apr;
2:100011.
PMID: 35481111
In low- and middle-income countries (LMICs), over 12 million people die yearly from chronic diseases and this number is expected to increase if concerted actions are not taken. The purpose...
12.
Okoro R
Explor Res Clin Soc Pharm
. 2022 Apr;
1:100008.
PMID: 35479506
The introduction of biological medicines has revolutionized the management of chronic diseases. Due to the high cost of biological medicine coupled with the fact that patents of many of these...
13.
Hedima E, Okoro R, Yelmis G, Adam H
Explor Res Clin Soc Pharm
. 2022 Feb;
5:100109.
PMID: 35128517
Objectives: To explore the impact of the COVID-19 pandemic and work on the mental health and wellbeing of pharmacists in Nigeria and investigate the risk of exhaustion, disengagement, burnout, and...
14.
Okoro R, Hedima E, Aguiyi-Ikeanyi C
J Am Pharm Assoc (2003)
. 2021 Oct;
62(1):79-85.e2.
PMID: 34654651
Background: Biopharmaceutical medicines have transformed the treatment of various long-term diseases, despite their high cost and limited availability. Due to their cost saving potentials, biosimilar medicines represent a new wave...
15.
Okoro R, Adibe M, Okonta M, Ummate I, Ohieku J, Yakubu S
Int Urol Nephrol
. 2021 Mar;
54(1):165-172.
PMID: 33772421
Purpose: Health-related quality of life (HRQoL) is increasingly being considered as a critical parameter to measure how the disease affects patients' health status, especially for long-term ailments like chronic kidney...
16.
Okoro R, Ummate I, Ohieku J, Yakubu S, Adibe M, Okonta M
J Patient Exp
. 2021 Jan;
7(6):1303-1309.
PMID: 33457579
The alarming rise in the incidence of end-stage renal disease in Nigeria is likely to continue if patients with chronic kidney disease (CKD) lack knowledge of this disease, its management,...
17.
Okoro R
Res Social Adm Pharm
. 2020 Dec;
17(1):1925-1928.
PMID: 33317766
The COVID-19 pandemic is putting enormous pressure on healthcare systems worldwide and various countries are struggling to flatten the curve to prevent their healthcare system from becoming overwhelmed. Studies have...
18.
Hedima E, Okoro R
Health Policy Technol
. 2020 Nov;
10(1):23-24.
PMID: 33169100
No abstract available.
19.
Okoro R, Muslim J, Biambo A
Int J Pharm Pract
. 2020 May;
28(4):395-404.
PMID: 32367604
Objectives: To assess the quality of life (QoL) of Nigerian pharmacy students and to investigate its predictors. Methods: This cross-sectional descriptive study randomly sampled one pharmacy school from each of...
20.
Okoro R, Nmeka C, Erah P
Afr Health Sci
. 2020 Mar;
19(3):2356-2364.
PMID: 32127805
Background: Subsidizing the cost of medicines through insurance schemes increases consumption of medicines and may contribute to irrational use of antibiotics. Objectives: To describe the systemic antibiotics prescriptions patterns and...